Testing effectiveness (Phase 2)Ended earlyNCT04370834
What this trial is testing
Tocilizumab for Patients With Cancer and COVID-19 Disease
Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmPneumonia+3 more
National Cancer Institute (NCI) 1